Collaboration

Main
Business Areas
Collaboration

Exploration of optimal target cancer types

RAPTOR AI™

Discovery of new indications for drugs

By partnering with collaborators, we maximize the value of drugs under development by expanding their indications within a short period and at minimal cost.

Input
- 01
  Drug-treated transcriptomic data
- 02
  Disease transcriptomic data
Output
- 01
  New indications
- 02
  Combination drug discovery

Target & Biomarker Discovery

Exploration of optimal target cancer types

Using the RAPTOR AI platform, we explore optimal therapeutic targets in specific cancer types and discover biomarkers.

Input
- 01
  Drug-treated transcriptomic data
- 02
  Cancer-type-specific omics data
Output
- 01
  Prediction of optimal target cancer types
- 02
  Biomarker discovery

Together with Oncocross, we create new opportunities in drug discovery, diagnostics,
and data-driven expansion.

Let's Build the Next Possibility in Precision Medicine

Collaboration

Discovery of new indications for drugs

Exploration of optimal target cancer types

Together with Oncocross, we create new opportunities in drug discovery, diagnostics,and data-driven expansion.

Together with Oncocross, we create new opportunities in drug discovery, diagnostics,
and data-driven expansion.